Suppr超能文献

肥胖是新冠疫情期间卫生系统恢复力面临的关键挑战。

Obesity as key challenge for the health systems resilience during the COVID-19 pandemic.

作者信息

Furtunescu F L, Pistol A

机构信息

"Carol Davila" University of Medicine and Pharmacy - Public Health and Management.

National Institute of Public Health - National Centre for Control and Surveillance of Communicable Diseases, Bucharest.

出版信息

Acta Endocrinol (Buchar). 2020 Oct-Dec;16(4):479-486. doi: 10.4183/aeb.2020.479.

Abstract

The COVID-19 pandemic affected 62 million people and caused more than 1.4 million deaths globally till the end of November 2020. Our study aimed to explore the association between obesity and the negative outcomes of COVID-19 worldwide. The prevalence of obesity and overweight per country was extracted from the World Health Organization information system and, for measuring the COVID-19 negative outcomes, we calculated the cumulated notification rate and the mortality for the interval since starting of pandemic till the 29 of November 2020. We explored the linear relationship between COVID-19 and obesity by a bivariate Spearman rank correlation, interpreted using the rule of thumb for 95% level of confidence. We found globally a positive, moderate, and statistically significant correlation between prevalence of obesity and overweight and the negative outcomes of COVID-19. Some of the results found at global level were confirmed in the disaggregated analysis per WHO regions. Due to the linear association of obesity with the COVID-19 negative outcomes, effective actions are needed for keeping the health systems resilience during the COVID-19. Preventing the obese and overweight people to be infected, prioritizing access to vaccination and to adequate care and treatment could be effective.

摘要

截至2020年11月底,新冠疫情已在全球影响了6200万人,并导致超过140万人死亡。我们的研究旨在探讨全球范围内肥胖与新冠疫情负面结果之间的关联。各国肥胖和超重的患病率数据取自世界卫生组织信息系统,为衡量新冠疫情的负面结果,我们计算了自疫情开始至2020年11月29日期间的累计通报率和死亡率。我们通过双变量Spearman等级相关性分析了新冠疫情与肥胖之间的线性关系,并根据95%置信水平的经验法则进行解读。我们发现,全球范围内肥胖和超重患病率与新冠疫情负面结果之间存在正相关、中等程度且具有统计学意义的关联。在按世界卫生组织区域进行的分类分析中,一些在全球层面得出的结果得到了证实。鉴于肥胖与新冠疫情负面结果之间存在线性关联,在新冠疫情期间需要采取有效行动以保持卫生系统的韧性。防止肥胖和超重人群感染、优先提供疫苗接种以及充分的护理和治疗可能会有效果。

相似文献

1
Obesity as key challenge for the health systems resilience during the COVID-19 pandemic.
Acta Endocrinol (Buchar). 2020 Oct-Dec;16(4):479-486. doi: 10.4183/aeb.2020.479.
3
Association between Obesity and COVID-19 Mortality in Peru: An Ecological Study.
Trop Med Infect Dis. 2021 Oct 7;6(4):182. doi: 10.3390/tropicalmed6040182.
4
Assessing sub-regional-specific strengths of healthcare systems associated with COVID-19 prevalence, deaths and recoveries in Africa.
PLoS One. 2021 Mar 1;16(3):e0247274. doi: 10.1371/journal.pone.0247274. eCollection 2021.
6
Does artificial light-at-night exposure contribute to the worldwide obesity pandemic?
Int J Obes (Lond). 2016 May;40(5):815-23. doi: 10.1038/ijo.2015.255. Epub 2016 Jan 22.
7
Updated overview on the interplay between obesity and COVID-19.
Diagnosis (Berl). 2020 Nov 19;8(1):5-16. doi: 10.1515/dx-2020-0111. Print 2021 Feb 23.
9
Are we ready to deal with a global COVID-19 pandemic? Rethinking countries' capacity based on the Global Health Security Index.
Int J Infect Dis. 2021 May;106:289-294. doi: 10.1016/j.ijid.2021.03.089. Epub 2021 Apr 3.

引用本文的文献

1
Management of thyroiditis in the context of Covid-19: cause-effect and beyond.
Acta Endocrinol (Buchar). 2023 Oct-Dec;19(4):471-479. doi: 10.4183/aeb.2023.471. Epub 2024 Jun 24.
2
MECHANICAL VENTILATION NEED AND GLYCEMIC STATUS IN PATIENTS WITH COVID -19: A FOLLOW-UP STUDY.
Acta Endocrinol (Buchar). 2022 Jul-Sep;18(3):306-315. doi: 10.4183/aeb.2022.306.
3
CHARACTERIZATION OF PATIENTS IN THE POST-ACUTE PHASE OF COVID-19 WHO PRESENTED THEMSELVES TO AN EMERGENCY DEPARTMENT.
Acta Endocrinol (Buchar). 2022 Apr-Jun;18(2):194-201. doi: 10.4183/aeb.2022.194.

本文引用的文献

1
HOW GENETICISTS CONTRIBUTE TO UNDERSTANDING OF COVID-19 DISEASE PATHOGENICITY.
Acta Endocrinol (Buchar). 2020 Jul-Sep;16(3):346-352. doi: 10.4183/aeb.2020.346.
2
Fragmented health systems in COVID-19: rectifying the misalignment between global health security and universal health coverage.
Lancet. 2021 Jan 2;397(10268):61-67. doi: 10.1016/S0140-6736(20)32228-5. Epub 2020 Dec 1.
3
Lancet COVID-19 Commission Statement on the occasion of the 75th session of the UN General Assembly.
Lancet. 2020 Oct 10;396(10257):1102-1124. doi: 10.1016/S0140-6736(20)31927-9. Epub 2020 Sep 14.
4
Obesity: A critical risk factor in the COVID-19 pandemic.
Clin Obes. 2020 Dec;10(6):e12403. doi: 10.1111/cob.12403. Epub 2020 Aug 28.
5
Individuals with obesity and COVID-19: A global perspective on the epidemiology and biological relationships.
Obes Rev. 2020 Nov;21(11):e13128. doi: 10.1111/obr.13128. Epub 2020 Aug 26.
6
COVID-19 and Morbid Obesity: Associations and Consequences for Policy and Practice.
World Med Health Policy. 2020 Dec;12(4):512-532. doi: 10.1002/wmh3.361. Epub 2020 Aug 9.
8
Obesity and Mortality Among Patients Diagnosed With COVID-19: Results From an Integrated Health Care Organization.
Ann Intern Med. 2020 Nov 17;173(10):773-781. doi: 10.7326/M20-3742. Epub 2020 Aug 12.
9
Unfavorable influence of prematurity on the neonatal prognostic of small for gestational age fetuses.
Exp Ther Med. 2020 Sep;20(3):2415-2422. doi: 10.3892/etm.2020.8744. Epub 2020 May 13.
10
ENDOCRINE EFFECTS OF COVID 19: DIFFICULTIES IN THE MANAGEMENT OF ENDOCRINE DISORDERS FROM INDIVIDUAL TO SOCIETIES.
Acta Endocrinol (Buchar). 2020 Jan-Mar;16(1):74-77. doi: 10.4183/aeb.2020.74.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验